Literature DB >> 23829279

Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth in HMGA1 transgenic model of T-cell leukemia.

Joelle Hillion1, Amy M Belton, Sandeep N Shah, James Turkson, Naijie Jing, David J Tweardy, Francescopaolo di Cello, David L Huso, Linda M S Resar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23829279      PMCID： PMC4390121          DOI： 10.3109/10428194.2013.821202

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

1.  Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.

Authors:  Naijie Jing; Qiqing Zhu; Ping Yuan; Yidong Li; Li Mao; David J Tweardy
Journal:  Mol Cancer Ther       Date:  2006-02       Impact factor: 6.261

2.  Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity.

Authors:  James Turkson; Shumin Zhang; Jay Palmer; Heidi Kay; Joseph Stanko; Linda B Mora; Said Sebti; Hua Yu; Richard Jove
Journal:  Mol Cancer Ther       Date:  2004-12       Impact factor: 6.261

Review 3.  Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.

Authors:  Clemens Grabher; Harald von Boehmer; A Thomas Look
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

4.  The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?

Authors:  Joelle Hillion; Surajit Dhara; Takita Felder Sumter; Mita Mukherjee; Francescopaolo Di Cello; Amy Belton; James Turkson; Souyma Jaganathan; Linzhao Cheng; Zhaohui Ye; Richard Jove; Peter Aplan; Ying-Wei Lin; Kelsey Wertzler; Ray Reeves; Ossama Elbahlouh; Jeanne Kowalski; Raka Bhattacharya; Linda M S Resar
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Stuart S Winter; Zeyu Jiang; Hadya M Khawaja; Timothy Griffin; Meenakshi Devidas; Barbara L Asselin; Richard S Larson
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

6.  Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis.

Authors:  Francescopaolo Di Cello; Surajit Dhara; Alexandra C Hristov; Jeanne Kowalski; Ossama Elbahloul; Joelle Hillion; Sujayita Roy; Jules P P Meijerink; Stuart S Winter; Richard S Larson; David L Huso; Linda Resar
Journal:  Leuk Lymphoma       Date:  2013-02-01

7.  HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia.

Authors:  Sujayita Roy; Francescopaolo Di Cello; Jeanne Kowalski; Alexandra C Hristov; Hua-Ling Tsai; Deepa Bhojwani; Julia A Meyer; William L Carroll; Amy Belton; Linda M S Resar
Journal:  Leuk Lymphoma       Date:  2013-04-30

8.  G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.

Authors:  Naijie Jing; Yidong Li; Weijun Xiong; Wei Sha; Ling Jing; David J Tweardy
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

9.  HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks.

Authors:  Sandeep N Shah; Candace Kerr; Leslie Cope; Elias Zambidis; Cyndi Liu; Joelle Hillion; Amy Belton; David L Huso; Linda M S Resar
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

10.  HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.

Authors:  Sandeep N Shah; Leslie Cope; Weijie Poh; Amy Belton; Sujayita Roy; C Conover Talbot; Saraswati Sukumar; David L Huso; Linda M S Resar
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240
View more
  7 in total

Review 1.  The high mobility group A1 molecular switch: turning on cancer - can we turn it off?

Authors:  Tait H Huso; Linda M S Resar
Journal:  Expert Opin Ther Targets       Date:  2014-03-31       Impact factor: 6.902

2.  Hitting the bull's eye: targeting HMGA1 in cancer stem cells.

Authors:  Breann L Yanagisawa; Linda M S Resar
Journal:  Expert Rev Anticancer Ther       Date:  2014-01       Impact factor: 4.512

Review 3.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

4.  STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.

Authors:  Amy Belton; Lingling Xian; Tait Huso; Michael Koo; Li Z Luo; James Turkson; Brent D G Page; Patrick T Gunning; Guosheng Liu; David L Huso; Linda M S Resar
Journal:  Leuk Lymphoma       Date:  2016-03-08

Review 5.  The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies.

Authors:  Loukik Arora; Alan Prem Kumar; Frank Arfuso; Wee Joo Chng; Gautam Sethi
Journal:  Cancers (Basel)       Date:  2018-09-13       Impact factor: 6.639

Review 6.  HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!

Authors:  Mireia Pujals; Linda Resar; Josep Villanueva
Journal:  Biomolecules       Date:  2021-09-09

7.  Covalent Bi-Modular Parallel and Antiparallel G-Quadruplex DNA Nanocostructs Reduce Viability of Patient Glioma Primary Cell Cultures.

Authors:  Valeria Legatova; Nadezhda Samoylenkova; Alexander Arutyunyan; Vadim Tashlitsky; Elena Zavyalova; Dmitry Usachev; Galina Pavlova; Alexey Kopylov
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.